OnCo
technologiesTechnologyApproved

PSK (Krestin) mushroom polysaccharide as adjuvant therapy

PSK, a protein-bound polysaccharide from the turkey tail mushroom, has been an approved adjuvant cancer drug in Japan since 1977. Meta-analyses of Japanese randomised trials in stomach and bowel cancer found a modest survival benefit added to chemotherapy, but these results have never been tested outside Japan.